Filter results
You can narrow down the results using the filters
Audience
Publication type
Topics
Our work
Diseases
9198 results
-
PBS price reduction: Lower prescription costs for Medicare and concession card holders – A3 Poster
This poster highlights PBS medicine costs dropping to $25 for Medicare card holders from 1 January 2026, with concession card holders continuing to pay $7.70. It promotes savings on prescriptions through the PBS. -
PBS co‑payment freeze: What it means for concession card holders – Fact sheet
This fact sheet explains the PBS concessional co‑payment freeze, keeping medicine costs capped at $7.70 until 2030. It outlines how the freeze works, ways to save on medicines, and where to find more information. -
PBS price reduction: What the lower co‑payment means for you – Fact sheet
This fact sheet explains the reduction of the PBS patient co‑payment to $25 for Medicare card holders and the continued $7.70 cap for concession card holders. It outlines how the PBS works and how the changes make medicines more affordable. -
Cheaper Medicines: FAQ’s about the lower PBS co‑payment
This FAQ explains how the reduced PBS co‑payment helps Australians save on medicines, what the changes mean for general and concession card holders, and how costs, Safety Net thresholds, and brand premiums may affect what you pay. -
Following vaccination – what to expect and what to do
This resource provides easy-to-read information on common reactions that may occur after vaccinations. -
Certification statement – PBS Awareness Campaign (Phase 3: Co-payment Reduction)
This certification statement, signed by A/g Secretary Professor Anthony Lawler on 5 January 2025, certifies that PBS Awareness Campaign (Phase 3: Co-payment Reduction) complies with relevant guidelines and policies. -
Public Register – Data matching activities
This public register records data matching undertaken for Medicare compliance purposes. Part VIIIA of the National Health Act 1953 requires the Chief Executive Medicare to maintain this register. -
GP Training Incentive Payments Fact sheet and FAQs
This fact sheet provides a summary on the GP Training Incentive Payments and frequently asked questions. -
New regulatory model – Guidance for Allied Health Professionals
We’ve developed guidance for allied health professionals about their options for providing services to older people under the new Aged Care Act and regulatory model.
-
NDIS new framework planning: what we heard summary report
Report summarising disability sector feedback on proposed NDIS new framework planning. Provides insights from consultations and webinars that will guide new rules and future public engagement. -
GP Training Incentive Payments Policy
This document outlines policy information about the GP Training Incentive Payments for GP registrars. -
Cheaper Medicines: PBS price changes for Medicare and concession card holders – Postcard
This postcard highlights PBS patient costs dropping to a maximum of $25 for Medicare card holders from 1 January 2026, while concession card holders continue to pay $7.70 until 2030. -
PBS co‑payment freeze : Cheaper medicines for concession card holders – A3 Poster
This poster highlights that concession card holders will pay no more than $7.70 per PBS medicine until 2030. It promotes access to over 900 subsidised medicines through the PBS. -
Cheaper Medicines: Key facts about lower PBS medicine costs infographic
This infographic highlights changes to PBS medicine costs, including a $25 cap for Medicare card holders and co-payment freeze for concession card holders until 2030, applying to more than 900 subsidised medicines. -
GP resource – Australian Government-funded mental health supports
A resource for GPs outlining available Australian Government-funded mental health supports. -
National Aged Care Advisory Council communique – November 2025
The meeting of the National Aged Care Advisory Council was held on the 19 November 2025. -
ATAGI statement: Counterfeit Rabies vaccine (Abhayrab®) reported in India: Guidance for travellers and healthcare providers
Counterfeit Abhayrab® rabies vaccines have been circulating in India since 2023. Travellers vaccinated there since Nov 2023 may be unprotected and should replace invalid doses with Australian‑registered vaccines. Healthcare providers should follow ATAGI guidance. -
COVID-19 vaccine rollout update – 1 January 2026
This presentation, delivered on 1 January 2026, contains an update to Australia's COVID-19 vaccine rollout. -
Gap Analysis of barriers to general practice accreditation 2024
This report provides a gap analysis of the barriers that prevent unaccredited general practices from seeking and achieving accreditation under the National General Practice Accreditation Scheme, and identifies factors that could motivate or support them to attain accreditation. -
COVID-19 vaccination – Local Government Area (LGA) – 1 January 2026
These reports list the percentage of people who have been vaccinated against COVID-19 by local government area (LGA). -
Changes to Star Ratings – Compliance rating fact sheet
We are making changes to the way the Compliance rating for Star Ratings is calculated. This fact sheet explains how and when the changes will commence. -
Sparked Program Review – Evaluation Report 2023–2025
The Sparked Program Review independently assesses Australia’s first Health Level 7 (HL7) Fast Healthcare Interoperability Resources (FHIR) Accelerator, and measures its progress and impact in advancing FHIR standards for digital health interoperability. It draws on 18 months of phased engagement. -
QI Program data recording templates
This data recording template is for registered providers to record QI Program data for a single aged care home. This template calculates and summarises data for each quality indicator for submission through the Government Provider Management System. -
Training and professional development opportunities for aged care workers
Information about free and government subsidised opportunities to support workers in building and refining their professional aged care skills. -
Prescribed List post-listing review framework
We have developed a Prescribed List Post-listing Review Framework that is used to guide the post-listing review process as part of the Prescribed List Reforms.